Science· 2017Q1
Chemogenetics revealed: DREADD occupancy and activation via converted clozapine
- 1,042citations
- Q1SCImago
- 2017year
Short summary
Clozapine, not clozapine N-oxide (CNO), is the active metabolite that binds to and activates DREADDs in the brain after systemic CNO injection.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Cellular and Molecular Neuroscience
Cellular and Molecular NeuroscienceNeuroscience